Volume : 13, Issue : 01, January – 2026
Title:
POST-CARDIAC SURGERY ATRIAL FIBRILLATION UK PRACTICE SURVEY
Authors :
Ramy Abdallah, Abdulrahman Showayhi, Abdalmjeed Albreki,Omar Altowelli, Robaa Alsobhi,Faris Khan, Ghadah Alshehri
Abstract :
Introduction:Recommendations for the prevention of postoperative atrial fibrillation (POAF) after cardiac surgery vary among international organizations. To establish “usual care” for a future platform trial aimed at preventing and managing POAF, a national survey of UK practice was conducted. In parallel, current international guidelines addressing the prevention and management of atrial fibrillation following cardiac surgery were reviewed to contextualize the survey findings.
Objectives: Postoperative atrial fibrillation affects approximately 30% of patients undergoing cardiac surgery and represents the most common postoperative complication. This study aimed to evaluate current UK practice in the prevention and management of POAF and to compare it with existing guideline recommendations.
Design:
A mixed-methods study comprising a structured literature review and a national online survey.
Participants
All 35 National Health Service (NHS) cardiac surgery centers in the United Kingdom were invited to participate through a national research network.
Measurements and Key Findings
Five major international guidelines were identified. All recommended β-blockade for the prevention of POAF. Both rate and rhythm control strategies were advised for treatment, with cardioversion reserved for hemodynamically unstable patients. Anticoagulation was recommended for patients remaining in atrial fibrillation beyond 48 hours, with continued rhythm and anticoagulation therapy guided by extended monitoring.
Responses were received from 31 of 35 centers (89%). Eleven centers (35.5%) followed local POAF prevention guidelines, four (13%) followed Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthesiology guidelines, four followed National Institute for Health and Care Excellence (NICE) guidance, and four adhered to other protocols. Eight centers (26%) reported having no formal POAF prevention protocol, and 28 centers (90%) did not perform routine POAF risk stratification. Most centers (23/31, 74%) lacked a structured POAF care bundle, although 14 centers (45%) actively attempted prophylaxis in patients presenting in sinus rhythm. The most commonly used preventive strategies were postoperative β-blockers (23/31, 74%), magnesium supplementation (20/31, 64.5%), and maintenance of serum potassium around 4.5 mmol/L (26/31, 84%).
Conclusions:β-blockade remains the cornerstone of POAF prevention following cardiac surgery. In UK practice, β-blockers alongside optimization of serum potassium and magnesium levels constitute the principal preventive measures. Despite the high incidence of POAF, formal risk stratification and standardized prevention pathways are not widely implemented, highlighting a significant opportunity for systematized intervention and future clinical trials.
Cite This Article:
Please cite this article in press Ramy Abdallah et al., Post-Cardiac Surgery Atrial Fibrillation Uk Practice Survey , Indo Am. J. P. Sci, 2026; 13(01)..
REFERENCES:
1. NICOR: National adult cardiac surgery audit 2017-20. National Institute of Cardiac Outcomes Research; 2021.
2. NHS England. National Cost Collection 2020-21. Available at: https:// www.england.nhs.uk/costing-in-the-nhs/national-cost-collection/#ncc1819.
3. Mariscalco G, Klersy C, Zanobini M, et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation 2008;118:1612–8.
4. Dobrev D, Aguilar M, Heijman J, et al. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol 2019; 16:417–36.
5. Ahlsson A, Fengsrud E, Bodin L, et al. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. Eur J Cardiothorac Surg 2010;37:1353–9.
6. El-Chami MF, Kilgo P, Thourani V, et al. New-onset atrial fibrillation pre- dicts long-term mortality after coronary artery bypass graft. J Am Coll Car- diol 2010;55:1370–6.
7. Hravnak M, Hoffman LA, Saul MI, et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. Am J Crit Care 2002;11:228–38.
8. Lai FY, Abbasciano RG, Tabberer B, et al. Identifying research priorities in cardiac surgery: A report from the James Lind Alliance Priority Setting Partnership in adult heart surgery. BMJ Open 2020;10:e038001.
9. Burrage PS, Low YH, Campbell NG, et al. New-onset atrial fibrillation in adult patients after cardiac surgery. Curr Anesthesiol Rep 2019;9:174–93.
10. National Institute of Health and Care Excellence. NG 196: Atrial fibrilla- tion: Diagnosis and management.
11. O’Brien B, Burrage PS, Ngai JY, et al. Society of Cardiovascular Anes- thesiologists/European Association of Cardiothoracic Anaesthetists prac- tice advisory for the management of perioperative atrial fibrillation in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2019; 33:12–26.
12. UK Health Research Authority Decision Tool. Available at: https://www. hra-decisiontools.org.uk/research/.
13. Gibbison B, Murphy GJ, Akowuah E, et al. Pre-operative and prehabilita- tion services in UK cardiac surgery centres. Anaesthesia 2023;78:388–91.
14. Gibbison B, EC de Cothi. Care pathways to prevent, identify, and treat delirium in United Kingdom cardiac surgery centers. J Cardiothorac Vasc Anesth 2024;38:348–9.
15. Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian Cardiovascu- lar Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol 2020;36:1847–948.
16. Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/ HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circula- tion 2024;83:109–279.
17. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diag- nosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the special contri- bution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373–498.
18. Fleet H, Pilcher D, Bellomo R, et al. Predicting atrial fibrillation after car- diac surgery: A scoping review of associated factors and systematic review of existing prediction models. Perfusion 2023;38:92–108.
19. D’Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Sur- geons Adult Cardiac Surgery Database: 2018 Update on outcomes and quality. Ann Thorac Surg 2018;105:15–23.
20. Blessberger H, Lewis SR, Pritchard MW, et al. Perioperative beta- blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev 2019;9: CD013438.
21. White KC, Laupland KB, Bellomo R, et al. Trials and the importance of usual care. Crit Care 2024;28:223.
22. Campbell NG, Allen E, Sanders J, et al. The impact of maintaining serum potassium ≥3.6 mEq/L vs ≥4.5 mEq/L on the incidence of new-onset atrial fibrillation in the first 120 hours after isolated elective coronary artery bypass grafting—Study protocol for a randomised feasibility trial for the proposed Tight K randomized non-inferiority trial. Trials 2017;18:618.
23. Wennberg JE. Unwarranted variations in healthcare delivery: Implications for academic medical centres. BMJ 2002;325:961–4.